Mark Robbins, PhD, JD

Adjunct Professor, Department of Pharmacology
Mark Robbins



Adjunct Professor, Department of Pharmacology
Adjunct Associate Professor, Department of Experimental and Clinical Pharmacology (ECP)
President and CEO, Kodiak Strategic Consultants
Acting CEO, GigaMune Therapeutics


Anatomy, University of Minnesota, Minneapolis, MN

Pharmacology, University of Minnesota, Minneapolis, MN

Biochemistry, UCLA, Los Angeles, CA

Law, St. Louis University, St. Louis, MO

Expand all


Mark received his B.S. degree in Biochemistry from UCLA and his Ph.D. in Pharmacology from the University of Minnesota Medical School. He completed his postdoctoral training under Drs. Robert Sorenson and Robert Elde, in the Department of Anatomy at the Unviersity of Minnesota Medical School.

Following his scientific training, Mark obtained a J.D. degree magna cum laude from Saint Louis University School of Law. Mark has over 35 years of broad-based drug research and development and commercialization experience in both start-up and fully integrated pharmaceutical/biotechnology companies.

His therapeutic areas of interest include CNS, cardiovascular, oncology, endocrine/metabolic, women’s heath, and diagnostic medicine. He provides strategic assistance to entrepreneurs with starting up and financing biotech ventures. Mark is President of Kodiak Strategic Consultants, which assists in developing and implementing regulatory/clinical strategies leading to successful NDA/BLA approvals.

Professional Associations

Minnesota State Bar Association

Academic Interests and Focus

Pharmaceutical and biotechnology drug development

Teaching Areas

Pharmaceutical and biotechnology regulations